Coverart for item
The Resource Pharmaceutical industry : innovation and developments, David A. Mancuso and Isobel M. Grenada, editors, (electronic resource)

Pharmaceutical industry : innovation and developments, David A. Mancuso and Isobel M. Grenada, editors, (electronic resource)

Label
Pharmaceutical industry : innovation and developments
Title
Pharmaceutical industry
Title remainder
innovation and developments
Statement of responsibility
David A. Mancuso and Isobel M. Grenada, editors
Contributor
Subject
Language
eng
Cataloging source
DNLM/DLC
Dewey number
615/.19
LC call number
RM301.25
LC item number
.P428 2011
NLM call number
QV 736
http://library.link/vocab/relatedWorkOrContributorName
  • Mancuso, David A
  • Grenada, Isobel M
Series statement
Business issues, competition and entrpreeurship
http://library.link/vocab/subjectName
  • Drug development
  • Pharmaceutical industry
  • Drugs
  • Drug Industry
  • Drug Industry
  • Drug Discovery
  • Drugs, Generic
Label
Pharmaceutical industry : innovation and developments, David A. Mancuso and Isobel M. Grenada, editors, (electronic resource)
Instantiates
Publication
Bibliography note
Includes bibliographical references index
Contents
  • Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO
  • Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO
  • Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO
Control code
OCM1bookssj0000569772
Dimensions
26 cm.
Dimensions
unknown
Extent
ix, 182 p.
Governing access note
License restrictions may limit access
Isbn
9781612093949
Isbn Type
(hardcover)
Lccn
2011003550
Other physical details
ill.
Specific material designation
remote
System control number
(WaSeSS)ssj0000569772
Label
Pharmaceutical industry : innovation and developments, David A. Mancuso and Isobel M. Grenada, editors, (electronic resource)
Publication
Bibliography note
Includes bibliographical references index
Contents
  • Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO
  • Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO
  • Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R&D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R&D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO
Control code
OCM1bookssj0000569772
Dimensions
26 cm.
Dimensions
unknown
Extent
ix, 182 p.
Governing access note
License restrictions may limit access
Isbn
9781612093949
Isbn Type
(hardcover)
Lccn
2011003550
Other physical details
ill.
Specific material designation
remote
System control number
(WaSeSS)ssj0000569772

Library Locations

    • Thomas Jefferson LibraryBorrow it
      1 University Blvd, St. Louis, MO, 63121, US
      38.710138 -90.311107
Processing Feedback ...